Blog | HemaCare

Scientists Engineer Diaphragm in the Lab using Stem Cells

Jan 8, 2016 1:00:01 PM / by Shweta posted in cell therapy, regenerative medicine, research, Stem Cell Therapy, stem cell transplantation, stem cells, tissue engineering

0 Comments

Stem cells were instrumental in creating new functional diaphragm

The diaphragm is a one of the vital organs of the body; it is responsible for several important functions including its very critical role in respiration. During the process of breathing, the diaphragm contracts to add volume to the thoracic cavity, which enables the lungs to make room for more air. It also separates the thoracic and abdominal cavities. The malfunction of the diaphragm can lead to several life threatening conditions, which can be acquired or congenital. Congenital diaphragmatic hernias (CDH) are one of the most common birth defects (1:2500) caused by a malformation, or hole, in the diaphragm.

Read More

Stem Cell Technology Helps to Build a Miniature Beating Heart

Aug 19, 2015 1:00:02 PM / by Shweta posted in Assay Development, drug screening, induced pluripotent stem cells, Innovation, regenerative medicine, research, stem cells, tissue engineering

0 Comments

Scientists created a tiny heart in the lab using stem cells

Stem cell research is continuously evolving and will likely become more and more effective in the near future. Researchers are continuously making efforts to grow stem cell-based organs in the lab using 3D modeling. Developing patient-specific organs to replenish degenerated organs or to screen drugs is a Holy Grail for the revolutionary tissue engineering field.

Read More

Building Lungs in the Lab with Stem Cells

Aug 17, 2015 1:00:03 PM / by Shweta posted in Chronic obstructive pulmonary disease, mesenchymal stem cells, regenerative medicine, research, Stem Cell Therapy, stem cells, tissue engineering

0 Comments

Stem cells discovery paves the way for the treatment of pulmonary disease

Chronic obstructive pulmonary disease (COPD) is a major cause of significant morbidity and mortality worldwide. According to the World Health Organization (WHO), more than 64 million people around the world have moderate to severe COPD. It is now the third leading cause of death in the United States, responsible for around 5% of global deaths every year. It has been estimated that in the next 10 years the total death rate may rise by more than 30%.

Read More

Efficient Way to Generate iPSCs for the Treatment of Multiple Sclerosis

Oct 13, 2014 1:00:01 PM / by Shweta posted in Brain Inflammation, disease-state cells, Independent validation, induced pluripotent stem cells, Innovation, iPSCs, regenerative medicine, research, stem cell therapy, stem cells, tissue engineering

0 Comments

Scientists have developed an accelerated protocol to generate functional oligodendrocytes for the treatment of multiple sclerosis

In one of our previous blogs we have described that Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by brain inflammation, which arises when the nervous system is attacked by the body’s own immune cells. MS can develop because of viral infection, genetic defects or environmental factors. As yet, the exact etiology of the disease is unfortunately unknown.

Read More

The Promise of Pluripotent Stem Cells for Age Related Macular Degeneration

Jun 30, 2014 1:00:47 PM / by Shweta posted in Age related macular degeneration, aging, AMD, cellular reprogramming, induced pluripotent stem cells, Innovation, iPSCs, research, stem cells, tissue engineering

0 Comments

Pluripotent stem cells offer a new prototype for Age Related Macular Degeneration modeling and therapies.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts